The overall survival (OS) of patients with non-M3 AML was associated with the mRNA expression levels of RhoBTB1, RhoBTB3, RhoC, and RhoF, as indicated by the survival curve (log‐rank test, P<0.05) (Figure 2A-D). This evidence concerns the gene RHOBTB1 and acute myeloid leukemia.